The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome
Macrophages are cells that mediate both innate and adaptive immunity reactions, playing a major role in both physiological and pathological processes. Systemic SARS-CoV-2-associated complications include acute respiratory distress syndrome (ARDS), disseminated intravascular coagulation syndrome, edema, and pneumonia. These are predominantly effects of massive macrophage activation that collectively can be defined as macrophage activation syndrome. In this review we focus on the role of macrophages in COVID-19, as pathogenesis of the new coronavirus infection, especially in cases complicated by ARDS, largely depends on macrophage phenotypes and functionalities. We describe participation of monocytes, monocyte-derived and resident lung macrophages in SARS-CoV-2-associated ARDS and discuss possible utility of cell therapies for its treatment, notably the use of reprogrammed macrophages with stable pro- or anti-inflammatory phenotypes.
Citations by journals
1
2
3
4
5
6
7
|
|
Frontiers in Immunology
|
Frontiers in Immunology
7 publications, 11.48%
|
Biomedicines
|
Biomedicines
4 publications, 6.56%
|
PeerJ
|
PeerJ
2 publications, 3.28%
|
EBioMedicine
|
EBioMedicine
2 publications, 3.28%
|
Vaccines
|
Vaccines
1 publication, 1.64%
|
Journal of Inflammation Research
|
Journal of Inflammation Research
1 publication, 1.64%
|
Frontiers in Molecular Biosciences
|
Frontiers in Molecular Biosciences
1 publication, 1.64%
|
Journal of the American Heart Association
|
Journal of the American Heart Association
1 publication, 1.64%
|
Cells
|
Cells
1 publication, 1.64%
|
Life
|
Life
1 publication, 1.64%
|
Genes
|
Genes
1 publication, 1.64%
|
Frontiers in Cell and Developmental Biology
|
Frontiers in Cell and Developmental Biology
1 publication, 1.64%
|
Journal of Clinical Medicine
|
Journal of Clinical Medicine
1 publication, 1.64%
|
Drug Delivery and Translational Research
|
Drug Delivery and Translational Research
1 publication, 1.64%
|
Nature Immunology
|
Nature Immunology
1 publication, 1.64%
|
Critical Care
|
Critical Care
1 publication, 1.64%
|
Inflammation
|
Inflammation
1 publication, 1.64%
|
Nonlinear Dynamics
|
Nonlinear Dynamics
1 publication, 1.64%
|
Seminars in Immunopathology
|
Seminars in Immunopathology
1 publication, 1.64%
|
Frontiers in Medicine
|
Frontiers in Medicine
1 publication, 1.64%
|
Cardiovascular Pathology
|
Cardiovascular Pathology
1 publication, 1.64%
|
Nuclear Medicine and Biology
|
Nuclear Medicine and Biology
1 publication, 1.64%
|
Life Sciences
|
Life Sciences
1 publication, 1.64%
|
Clinical Immunology
|
Clinical Immunology
1 publication, 1.64%
|
Molecular Therapy
|
Molecular Therapy
1 publication, 1.64%
|
Clinical and Experimental Medicine
|
Clinical and Experimental Medicine
1 publication, 1.64%
|
Allergy: European Journal of Allergy and Clinical Immunology
|
Allergy: European Journal of Allergy and Clinical Immunology
1 publication, 1.64%
|
Advanced healthcare materials
|
Advanced healthcare materials
1 publication, 1.64%
|
European Journal of Immunology
|
European Journal of Immunology
1 publication, 1.64%
|
1
2
3
4
5
6
7
|
Citations by publishers
2
4
6
8
10
12
|
|
Frontiers Media S.A.
|
Frontiers Media S.A.
11 publications, 18.03%
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
11 publications, 18.03%
|
Elsevier
|
Elsevier
11 publications, 18.03%
|
Wiley
|
Wiley
9 publications, 14.75%
|
Springer Nature
|
Springer Nature
8 publications, 13.11%
|
PeerJ
|
PeerJ
2 publications, 3.28%
|
Dove Medical Press
|
Dove Medical Press
1 publication, 1.64%
|
Oxford University Press
|
Oxford University Press
1 publication, 1.64%
|
2
4
6
8
10
12
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.